查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853483

大鼠和小鼠模型市场：按动物、模型类型、应用、最终用户、分销管道、研究类型和服务类型划分——2025-2032年全球预测

Rat & Mouse Model Market by Animal, Model Type, Application, End User, Distribution Channel, Research Type, Service Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，大鼠和小鼠模型市场将成长至 47.4 亿美元，复合年增长率为 8.56%。

主要市场统计数据
基准年 2024 24.5亿美元
预计年份：2025年 26.7亿美元
预测年份：2032年 47.4亿美元
复合年增长率 (%) 8.56%

现代小型哺乳动物临床前生态系统框架，重点在于模型选择、转化有效性和操作决策压力

依赖大鼠和小鼠模型的临床前研究生态系统正处于曲折点，这一转折点是由科学进步的汇聚、监管的改进以及商业化路径的转变所定义的。几十年来，这些小型哺乳动物模型提供了重要的机制见解，并建造了从实验室到临床的转化桥樑。然而，如今的研究要求对模型选择、测试设计和可重复性进行更严格的审查。研究人员和机构领导者越来越需要在转化相关性和运作限制之间权衡，因为在物种、遗传组成和服务方法方面的选择会对研究进度和科学成果产生重大影响。

要了解当前的研究格局，就必须理解基因工程的突破、表型分析技术的改进以及更严格的伦理和动物福利标准如何改变了人们对临床前平台的期望。这些变化凸显了整合资料策略、跨职能决策架构以及在研发早期制定明确的GO/NO（目的/否定）标准的必要性。因此，实验室负责人和申办方必须权衡小鼠和大鼠模型的持久价值与优化预测性能、降低变异性以及提供符合监管机构和支付方期望的检测方法的需求。

本文透过强调团队面临的实际权衡取舍，为后续分析奠定了基础：为生物学问题选择合适的模型类型、确保方法的严谨性，以及管理采购、饲养和资料组装物流。本执行摘要的主要目标是将这些高层次的动态转化为可操作的见解，供临床前研究领域的营运和策略决策者参考。

基因编辑、表型分析和外包等技术进步如何重塑临床前研究中的模型选择、测试设计和伦理实践

受技术成熟、科研重点转变和伦理规范发展等因素的推动，大鼠和小鼠模型研究格局已发生翻天覆地的变化。基因工程工具的出现使得建构高度特异性的模型成为可能，研究人员能够以前所未有的精确度建构与疾病相关的模型。这种技术能力促使研究团队转变假设检验的方法，从「一刀切」的模型转向根据所研究的机制问题和终点定制的模型。同时，表型分析和体内影像技术的进步提供了更丰富、多模态的读数，提高了临床前讯号的可解释性。

随着科学的转变，科学研究交付的组织模式也不断演变。科学研究赞助方越来越倾向于平衡内部能力与外包服务，选择委外研发机构）进行专业检测，同时保留核心的研发活动。这种混合模式影响采购、时间安排和资料所有权，凸显了供应商管治和品质保证通讯协定的重要性。此外，人们对伦理和动物福利的期望也不断提高，促使人们重新审视动物的饲养、环境改善和实验设计，以提升动物福利并减少混杂因素的影响。

总而言之，这些变化创造了一个更丰富但也更复杂的营运环境。那些能够将模型选择标准编纂成法、在测试设计早期整合先进的表型分析技术并建立清晰的供应商绩效指标的机构，将在将临床前讯号转化为可靠的概念验证数据方面获得实际优势。

评估2025年实施的累积关税如何迫使供应链增强韧性、重新设计采购流程以及临床前营运的地理迁移。

2025年实施的关税调整及相关贸易措施，为支持临床前研究的全球供应链带来了新的成本动态和营运考量。采购团队和设施管理人员在采购动物、专用饲料、设备和进口试剂时，如今面临更复杂的计算。鑑于育种项目、医疗用品和特殊耗材之间的相互依存关係，即使是小幅的关税上涨也会影响前置作业时间和库存策略。因此，相关人员采取更积极的供应商多元化策略，尽可能在地采购，并扩大安全库存规模，以降低供应中断的风险。

除了采购之外，关税主导的变化也影响企业在特定活动地点所进行的策略决策。赞助商和服务供应商正在重新评估繁殖基地、冷冻保存设施和专业表型分析中心的地理位置，以降低跨境成本波动带来的风险。监管机构和机构审查委员会越来越关注动物和材料的来源，促使企业制定更详细的采购文件和监管链（CoC）流程。

营运团队正透过加强与供应商的关係、协商更长期的合约以及投资供应链视觉化工具来应对，这些工具能够及早预警成本和交付风险。总而言之，2025年关税的累积影响迫使该行业采取更具韧性的筹资策略，并重新考虑其临床前营运的地域布局，以维持研究的连续性并控製成本。

主导细分市场，深入了解动物类型、模型建构、研究应用、最终用户、分销管道、研究类型和服务模式，从而将这些资讯与营运决策连结起来。

细分市场层面的洞察揭示了驱动大鼠和小鼠模型市场实验设计、供应商选择和产品组合优先排序的细微考虑因素。以动物物种划分，市场研究主要集中在小鼠和大鼠，这种根本性的二分法会影响生理相关性、研究范围和饲养需求。小鼠通常是基因操作的主要平台，而大鼠则常用于需要更大血容量的研究或受益于更复杂认知能力的行为分析。按模型类型划分，市场研究涵盖疾病特异性模型、基因敲除模型、基因转殖模型和异种移植模型，其中疾病特异性模型进一步细分为心血管疾病模型、感染疾病模型、神经系统疾病模型和肿瘤模型。基因敲除模型、基因转殖模型和疾病特异性模型之间的选择取决于机制问题、所需的表型保真度以及下游转化应用的考量。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • CRISPR/Cas9介导的基因编辑技术在小鼠肿瘤学研究的应用日益广泛
  • 为加速免疫肿瘤药物研发，人源化小鼠模型的需求日益增长
  • 扩大无菌和无菌大鼠模型在微生物群和代谢研究中的应用
  • 扩展高性能表型分析和成像平台在囓齿动物筛检中的整合
  • 监管指南的改变正在推动对替代性体外和电脑模拟囓齿动物模型的需求。
  • 製药公司与合约研究机构在客製化囓齿动物模型方面加强合作

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章：以动物种类分類的大鼠和小鼠模型市场

  • 老鼠
  • 鼠

第九章 依模型类型分類的大鼠和小鼠模型市场

  • 疾病特异性
    • 心血管疾病
    • 感染疾病模型
    • 代谢紊乱
    • 神经系统疾病
    • 肿瘤模型
  • 昏死
  • 基因改造
  • 异种移植

第十章 按应用分類的大鼠和小鼠模型市场

  • 心血管系统
  • 免疫学
  • 感染疾病
  • 代谢紊乱
  • 神经病学
  • 肿瘤学
  • 整形外科

第十一章 按最终用户分類的大鼠和小鼠模型市场

  • 学术研究机构
  • CRO
  • 药物生物技术

第十二章 按分销管道分類的大鼠和小鼠模型市场

  • 直接地
  • 经销商

第十三章 依研究类型分類的大鼠和小鼠模型市场

  • ADME
  • 行动
  • 效力
  • 安全药理学
  • 毒理学

第十四章 按服务类型分類的大鼠和小鼠模型市场

  • 目录
  • 风俗

第十五章 各地区大鼠与小鼠模型市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章：依组别分類的大鼠和小鼠模型市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国大鼠与小鼠模型市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Charles River Laboratories International, Inc.
    • Envigo RMS, LLC
    • Taconic Biosciences, Inc.
    • The Jackson Laboratory
    • Janvier Labs SA
    • Biocytogen Pharmaceuticals Co., Ltd.
    • Oriental BioService Co., Ltd.
    • Crown Bioscience International, Inc.
    • GemPharmatech Co., Ltd.
    • TransTech Pharma, Inc.
Product Code: MRR-3A2E844FF329

The Rat & Mouse Model Market is projected to grow by USD 4.74 billion at a CAGR of 8.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.45 billion
Estimated Year [2025] USD 2.67 billion
Forecast Year [2032] USD 4.74 billion
CAGR (%) 8.56%

Framing the contemporary small mammal preclinical ecosystem with emphasis on model choice, translational validity, and operational decision-making pressures

The preclinical research ecosystem that relies on rat and mouse models sits at an inflection point defined by converging scientific advances, regulatory refinement, and shifting commercialization pathways. Over decades these small mammal models have provided indispensable mechanistic insight and a translational bridge from bench to bedside, yet today's studies demand closer scrutiny of model selection, study design, and reproducibility. Researchers and organizational leaders increasingly weigh translational validity against operational constraints, and they navigate an environment where choices about species, genetic construct, and service modality materially influence timelines and scientific outcomes.

Contextualizing the current landscape requires appreciation for how genetic engineering breakthroughs, improvements in phenotyping technologies, and more rigorous ethical and welfare standards have reshaped the expectations placed on preclinical platforms. These changes amplify the need for integrated data strategies, cross-functional decision frameworks, and clearer go/no-go criteria early in development. As such, laboratory leaders and sponsors must reconcile the enduring value of mouse and rat models with the imperative to optimize predictive performance, reduce variability, and align studies with regulatory and payer expectations.

This introduction frames the subsequent analysis by emphasizing the practical trade-offs teams face: selecting the right model type for a biological question, ensuring methodological rigor, and managing the logistics of sourcing, housing, and data integration. The core objective of this executive summary is to convert these high-level dynamics into actionable insight for those making operational and strategic decisions in preclinical research.

How technological advances in genetic editing, phenotyping, and operational outsourcing are reshaping model selection, study design, and ethical practices in preclinical research

The landscape of rat and mouse model research has undergone transformative shifts driven by technological maturation, shifting scientific priorities, and evolving ethical expectations. Genetic engineering tools have democratized the creation of highly specific model types, allowing researchers to pursue disease-relevant constructs with unprecedented precision. This technical capability has reoriented how teams approach hypothesis testing, moving away from one-size-fits-all models toward tailored constructs that match the mechanistic questions and endpoints under study. At the same time, phenotyping and in vivo imaging modalities have advanced to deliver richer, multimodal readouts that improve the interpretability of preclinical signals.

Parallel to these scientific shifts, organizational models for research delivery have evolved. Sponsors increasingly balance in-house capabilities with outsourced services, choosing contract research organizations for specialized assays while retaining core discovery activities internally. This hybrid approach affects procurement, timelines, and data ownership considerations, and it underscores the growing importance of vendor governance and quality assurance protocols. Ethical and welfare expectations have also heightened, prompting revised housing, enrichment, and experimental design practices that both improve animal welfare and reduce confounding variability.

Collectively, these shifts create a more capability-rich but also more complex operating environment. Organizations that codify decision criteria for model selection, integrate advanced phenotyping early in study design, and establish clear vendor performance metrics will gain a practical advantage in translating preclinical signals into robust proof-of-concept data.

Evaluating how the cumulative tariff actions enacted in 2025 compelled supply chain resilience, procurement redesign, and geographic reallocation of preclinical operations

Tariff policy changes and associated trade measures established for 2025 introduced new cost dynamics and operational considerations across global supply chains that support preclinical research. Procurement teams and facility managers now face a more complex calculus when sourcing animals, specialty diets, equipment, and imported reagents. Given the interdependence of breeding programs, medical supplies, and specialized consumables, even modest tariff increments can affect lead times and inventory strategies. Consequently, stakeholders have adopted more proactive supplier diversification, localized sourcing where feasible, and expanded safety stock strategies to mitigate disruption.

Beyond procurement, tariff-driven shifts influence strategic decisions about where to perform certain activities. Sponsors and service providers are re-evaluating the geographic allocation of breeding colonies, cryopreservation repositories, and specialized phenotyping centers to reduce exposure to cross-border cost volatility. Regulatory interactions also reflect this recalibration; agencies and institutional review boards are increasingly attentive to the provenance of animals and materials, prompting more detailed sourcing documentation and chain-of-custody processes.

Operational teams have responded by strengthening supplier relationships, negotiating longer-term contracts, and investing in supply chain visibility tools that provide early warning on cost and delivery risks. In sum, the cumulative impact of tariff actions in 2025 compelled the sector to adopt more resilient procurement strategies and to reexamine the geographic footprint of preclinical operations in order to maintain continuity of research and control costs.

Deep segmentation-driven understanding linking animal species, model constructs, research applications, end users, distribution channels, research types, and service modalities to operational decisions

Segment-level insight reveals the granular considerations that drive experimental design, vendor selection, and portfolio prioritization across the rat and mouse model landscape. Based on Animal, the market is studied across Mouse and Rat, and this fundamental dichotomy influences physiological relevance, study scope, and husbandry needs; mice often serve as the primary platform for genetic manipulations while rats are frequently preferred for studies requiring larger blood volumes or behavioral assays that benefit from greater cognitive complexity. Based on Model Type, the market is studied across Disease Specific, Knockout, Transgenic, and Xenograft constructs, with Disease Specific models further characterized across Cardiovascular Disorders, Infectious Disease Models, Metabolic Disorders, Neurological Disorders, and Oncology Models; the selection between knockout, transgenic, and disease-specific constructs is driven by the mechanistic question, required phenotype fidelity, and downstream translational considerations.

Based on Application, the market is studied across Cardiovascular, Immunology, Infectious Disease, Metabolic Disorder, Neurology, Oncology, and Orthopedic domains, and each application area imposes distinct endpoint requirements, assay complexity, and welfare considerations. Based on End User, the market is studied across Academic & Research Institutes, CROs, and Pharma & Biotech, and end-user priorities shape purchasing cycles, demand for bespoke services, and expectations for data packages and regulatory support. Based on Distribution Channel, the market is studied across Direct and Distributors, which affects lead times, pricing structures, and traceability. Based on Research Type, the market is studied across ADME, Behavioral, Efficacy, Safety Pharmacology, and Toxicology, and the chosen research type dictates study design complexity, required instrumentation, and regulatory documentation. Based on Service Type, the market is studied across Catalog and Custom options, with catalog services offering standardized, off-the-shelf models and custom services delivering bespoke genetic constructs and study formats tailored to unique scientific questions.

These segmentation dimensions intersect to create highly context-dependent decision pathways. For instance, an oncology xenograft study for a small-molecule efficacy readout will prioritize different vendors, housing conditions, and data packages than a neurological knockout model designed to elucidate disease mechanisms. Recognizing these interactions enables stakeholders to align procurement, ethical oversight, and data integration strategies with the nuanced demands of each experimental configuration.

Regional operational realities and regulatory nuances that determine model sourcing, study sequencing, and strategic placement of breeding and phenotyping capacity across global research hubs

Regional dynamics materially influence how organizations design studies, source resources, and plan regulatory strategies across the rat and mouse model landscape. In the Americas, research hubs combine a concentration of academic institutions, biotech startups, and integrated pharmaceutical R&D centers that demand rapid access to specialized models and high-throughput phenotyping; this environment fosters innovation in service delivery and a premium on speed and data completeness. Europe, Middle East & Africa presents a mosaic of regulatory frameworks and infrastructure maturity, where centers of excellence coexist with emerging markets; here, harmonization efforts and regional centers of breeding and phenotyping play an important role in enabling multicenter studies while ethical standards and welfare guidelines remain a focal point for operational planning. Asia-Pacific has rapidly expanded capacity in both commercial service provision and academic research, with significant investments in breeding infrastructure and specialized CRO capabilities; stakeholders in this region often emphasize cost-efficiency, scale, and the ability to execute high-volume study programs while increasingly meeting international standards for data quality and animal welfare.

Cross-regional collaboration and sample movement introduce logistical challenges that require clear chain-of-custody protocols and alignment on welfare and transport standards. Moreover, regional regulatory expectations and import/export controls shape how sponsors sequence studies across sites and choose where to domicile breeding colonies or long-term storage facilities. An informed regional strategy thus balances local capabilities with global coordination to optimize turnaround times, maintain compliance, and preserve the integrity of translational signals.

Competitive positioning insights illustrating how quality assurance, customization breadth, collaborative partnerships, and client service excellence drive market leadership

Leading companies that operate in the rat and mouse model ecosystem demonstrate a shared emphasis on quality assurance, customization capability, and integrated data services. Market-facing organizations that differentiate themselves invest in robust breeding programs, genetic validation workflows, and standardized phenotyping pipelines that reduce inter-study variability and improve reproducibility. In addition, service providers that offer modular packages-combining model generation, husbandry, in-life monitoring, and comprehensive data analytics-help sponsors shorten timelines and lower translational risk.

Partnerships and collaborations constitute another important axis of competitive positioning. Successful companies build deep scientific relationships with academia and industry, co-develop models for niche therapeutic areas, and participate in consortia that promote standardization. They also provide transparent quality metrics, traceability documentation, and regulatory support that align with sponsor expectations for preclinical dossiers. Companies that expand geographically while maintaining consistent husbandry and validation standards have demonstrated the ability to support multinational programs more reliably.

Finally, a focus on customer experience and technical support differentiates top-tier providers. Attention to study design consultation, responsive project management, and post-study data services creates enduring client relationships and positions these companies to capture a larger share of complex, high-value program work.

Practical and prioritized actions for leaders to strengthen model selection, supplier governance, early validation, data integration, and welfare practices to improve translational outcomes

Industry leaders should adopt a set of pragmatic actions to convert insight into operational advantage and enhance translational yield from rat and mouse studies. First, codify model-selection decision frameworks that tie biological hypothesis to model attributes, phenotyping requirements, and regulatory endpoints; such frameworks reduce subjective selection bias and clarify the trade-offs between transgenic constructs, knockout approaches, and disease-specific models. Next, invest in early-stage phenotyping and pilot studies to validate key endpoints before committing to large-scale efficacy programs; this staged approach reduces downstream failure risk and enables better resource allocation.

It is also critical to strengthen supplier governance and diversify sourcing strategies to mitigate exposure to regional disruptions and tariff-driven cost volatility. Establishing preferred-provider agreements that include performance metrics, data deliverables, and contingency clauses will improve reliability. Organizations should further embed data integration capabilities and digital phenotype repositories to amplify the value of in-life and terminal data, enabling meta-analyses and cross-study learning. Enhancing welfare and enrichment programs improves animal well-being and reduces experimental noise; aligning such practices with transparent reporting supports regulatory confidence and reproducibility.

Finally, cultivate strategic partnerships with providers that offer integrated, end-to-end services and prioritize readability of data packages. These partnerships should be evaluated not only on cost but on quality controls, validation documentation, and the ability to co-design studies that align with translational endpoints. Implementing these recommendations will improve decision velocity, reduce operational risk, and elevate the predictive value of preclinical work.

Transparent mixed-method research approach combining primary stakeholder interviews, technical literature alignment, vendor capability comparison, and supply chain scenario analysis

The findings summarized here rest on a mixed-method research approach that combined primary stakeholder engagement, rigorous literature synthesis, and comparative operational analysis. Primary research included structured interviews with institutional researchers, procurement leads, and service-provider operations managers to surface real-world constraints and priorities. The qualitative insights were triangulated with technical literature and regulatory guidance to ensure alignment with current best practices and evolving expectations for animal welfare, sourcing transparency, and study design.

Analysts also conducted a comparative review of vendor capabilities and service portfolios, assessing factors such as genetic validation processes, phenotyping depth, and data deliverable quality. The methodology prioritized reproducibility and traceability, placing particular emphasis on how suppliers document lineage, genotype confirmation, and study metadata. Supply chain resilience considerations were evaluated through scenario analysis focused on procurement lead times, import/export constraints, and supplier concentration risks.

Throughout the research process, efforts were made to remove promotional bias and to validate claims through cross-verification with multiple independent sources. The approach aimed to generate actionable insights while maintaining methodological transparency and reproducibility for readers seeking to evaluate or replicate the analysis.

Synthesis of strategic conclusions emphasizing how deliberate model selection, rigorous validation, integrated data strategies, and supply resilience improve translational success

In conclusion, rat and mouse models remain indispensable tools for preclinical discovery and development, yet their value depends on deliberate model selection, rigorous validation, and resilient operational practices. Advances in genetic engineering and phenotyping have expanded the range of experimental possibilities while raising the bar for quality assurance and reproducibility. Tariff-related supply chain pressures further incentivize proactive procurement strategies and geographic diversification of capabilities. Taken together, these forces demand that organizations align scientific choices with operational realities and embed stronger governance across sourcing, study design, and data management.

The optimal path forward emphasizes staged validation, integrated data strategies, and selective partnerships that provide both technical depth and logistical reliability. By doing so, sponsors and service providers can reduce translational risk, accelerate development decisions, and improve the scientific integrity of preclinical findings. The conclusions drawn here offer a strategic foundation for teams seeking to convert preclinical insight into clinically meaningful programs while managing cost, compliance, and operational complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of CRISPR/Cas9 mediated gene editing in mouse oncology research
  • 5.2. Growing demand for humanized mouse models to accelerate immuno-oncology drug discovery
  • 5.3. Expansion of germ-free and gnotobiotic rat models for microbiome and metabolic studies
  • 5.4. Increasing integration of high-throughput phenotyping and imaging platforms for rodent screening
  • 5.5. Shifts in regulatory guidelines driving demand for alternative in vitro and in silico rodent models
  • 5.6. Rising collaborations between pharmaceutical companies and contract research organizations for customized rodent models

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Rat & Mouse Model Market, by Animal

  • 8.1. Mouse
  • 8.2. Rat

9. Rat & Mouse Model Market, by Model Type

  • 9.1. Disease Specific
    • 9.1.1. Cardiovascular Disorders
    • 9.1.2. Infectious Disease Models
    • 9.1.3. Metabolic Disorders
    • 9.1.4. Neurological Disorders
    • 9.1.5. Oncology Models
  • 9.2. Knockout
  • 9.3. Transgenic
  • 9.4. Xenograft

10. Rat & Mouse Model Market, by Application

  • 10.1. Cardiovascular
  • 10.2. Immunology
  • 10.3. Infectious Disease
  • 10.4. Metabolic Disorder
  • 10.5. Neurology
  • 10.6. Oncology
  • 10.7. Orthopedic

11. Rat & Mouse Model Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. CROs
  • 11.3. Pharma & Biotech

12. Rat & Mouse Model Market, by Distribution Channel

  • 12.1. Direct
  • 12.2. Distributors

13. Rat & Mouse Model Market, by Research Type

  • 13.1. ADME
  • 13.2. Behavioral
  • 13.3. Efficacy
  • 13.4. Safety Pharmacology
  • 13.5. Toxicology

14. Rat & Mouse Model Market, by Service Type

  • 14.1. Catalog
  • 14.2. Custom

15. Rat & Mouse Model Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Rat & Mouse Model Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Rat & Mouse Model Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Charles River Laboratories International, Inc.
    • 18.3.2. Envigo RMS, LLC
    • 18.3.3. Taconic Biosciences, Inc.
    • 18.3.4. The Jackson Laboratory
    • 18.3.5. Janvier Labs SA
    • 18.3.6. Biocytogen Pharmaceuticals Co., Ltd.
    • 18.3.7. Oriental BioService Co., Ltd.
    • 18.3.8. Crown Bioscience International, Inc.
    • 18.3.9. GemPharmatech Co., Ltd.
    • 18.3.10. TransTech Pharma, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. RAT & MOUSE MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MOUSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MOUSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MOUSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MOUSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MOUSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MOUSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE MODELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE MODELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE MODELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE MODELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE MODELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY MODELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY MODELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY MODELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY MODELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY MODELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY MODELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY KNOCKOUT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY KNOCKOUT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY KNOCKOUT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY KNOCKOUT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY KNOCKOUT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY KNOCKOUT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TRANSGENIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TRANSGENIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TRANSGENIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TRANSGENIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TRANSGENIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TRANSGENIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY XENOGRAFT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY XENOGRAFT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY METABOLIC DISORDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMA & BIOTECH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMA & BIOTECH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMA & BIOTECH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMA & BIOTECH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ADME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ADME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ADME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ADME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ADME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ADME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BEHAVIORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BEHAVIORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BEHAVIORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BEHAVIORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BEHAVIORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BEHAVIORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EFFICACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EFFICACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EFFICACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EFFICACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EFFICACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EFFICACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SAFETY PHARMACOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SAFETY PHARMACOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SAFETY PHARMACOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SAFETY PHARMACOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SAFETY PHARMACOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SAFETY PHARMACOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CATALOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CATALOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CATALOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CATALOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CATALOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CATALOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CUSTOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CUSTOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CUSTOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CUSTOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CUSTOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CUSTOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY RESEARCH TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY DISEASE SPECIFIC, 2018-2024 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC RAT &